基于电子医疗记录的系统数据,基于快速眼进展的预测建模
Richul Oh1, Hyunjoong Kim2, Tae-Woo Kim1
1Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam, Gyeonggi-do, 13620, Republic of Korea.
Scientific reports
|April 16, 2025
概括
这项研究确定了关键的系统健康指标,预测了初级开角玻璃眼 (POAG) 患者的视网膜神经纤维层更快地变薄. 这些预测因素包括特定的血标记物和血压,有助于对青光眼的进展进行管理.
科学领域:
- 眼科医生 眼科 眼科
- 玻璃眼研究研究 玻璃眼研究
- 医疗数据分析 医学数据分析
背景情况:
- 主要开角青光眼 (POAG) 是不可逆转失明的主要原因.
- 预测视网膜神经纤维层 (RNFL) 稀薄的速度对于管理POAG进展至关重要.
- 系统因素在POAG进展中的作用需要进一步阐明.
研究的目的:
- 为了确定基线系统特征,预测POAG患者的快速RNFL稀释.
- 使用电子病历 (EMR) 开发和验证POAG进展的预测模型.
- 了解系统健康和眼部疾病进展之间的关系.
主要方法:
- 对POAG患者EMR数据的回顾性分析,追踪时间超过5年.
- 全球RNFL厚度每年使用光谱域光学连贯性断层扫描测量.
- 随机森林 (RF) 模型在系统数据上进行训练,以预测RNFL稀释率,使用SHAP值进行解释.
主要成果:
- 射频模型实现了0.88的R2,准确地预测了RNFL稀释.
- 确定了关键的系统预测因素:较高的阿斯巴酸氨基转移酶,较低的血糖,较低的系统血压和较高的HDL.
- 眼科因素,如较高的基线RNFL厚度和眼内压力也是显著的预测因素.
结论:
- 基线系统特征,包括特定的血液检测结果和血压,是POAG进展的有价值预测因素.
- 将系统性健康数据集成到预测模型中可以增强青光眼的治疗策略.
- 这项研究突出了对POAG的系统影响,并为个性化患者护理提供了见解.
相关概念视频
Glaucoma: Overview
475
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
475
Open Angle Glaucoma: Treatment
362
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
362


